• Login
    JavaScript is disabled for your browser. Some features of this site may not work without it.
    CANCER RISK IN MULTIPLE SCLEROSIS PATIENTS TAKING CLADRIBINE 
    •   QMRO Home
    • Blizard Institute
    • Centre for Neuroscience, Surgery and Trauma
    • CANCER RISK IN MULTIPLE SCLEROSIS PATIENTS TAKING CLADRIBINE
    •   QMRO Home
    • Blizard Institute
    • Centre for Neuroscience, Surgery and Trauma
    • CANCER RISK IN MULTIPLE SCLEROSIS PATIENTS TAKING CLADRIBINE
    ‌
    ‌

    Browse

    All of QMROCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects
    ‌
    ‌

    Administrators only

    Login
    ‌
    ‌

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    CANCER RISK IN MULTIPLE SCLEROSIS PATIENTS TAKING CLADRIBINE

    View/Open
    Accepted version (12.77Kb)
    Volume
    85
    DOI
    10.1136/jnnp-2014-309236.140
    Issue
    10
    ISSN
    0022-3050
    Metadata
    Show full item record
    Authors
    Pakpoor, J; Disanto, G; Altmann, DR; Pavitt, S; Turner, B; Calado-Marta, M; Juliusson, G; Baker, D; Chataway, J; Schmierer, K
    URI
    http://jnnp.bmj.com/citmgr?gca=jnnp%3B85%2F10%2Fe4-at
    http://qmro.qmul.ac.uk/xmlui/handle/123456789/7246
    Collections
    • Centre for Neuroscience, Surgery and Trauma [1145]
    Twitter iconFollow QMUL on Twitter
    Twitter iconFollow QM Research
    Online on twitter
    Facebook iconLike us on Facebook
    • Site Map
    • Privacy and cookies
    • Disclaimer
    • Accessibility
    • Contacts
    • Intranet
    • Current students

    Modern Slavery Statement

    Queen Mary University of London
    Mile End Road
    London E1 4NS
    Tel: +44 (0)20 7882 5555

    © Queen Mary University of London.